Drug Development Executive

Drug Development Executive

Share this post

Drug Development Executive
Drug Development Executive
Interferon-𝝰 in the causal pathway of Sjögren Disease
Basic/Translational Sciences

Interferon-𝝰 in the causal pathway of Sjögren Disease

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
Jun 12, 2025
∙ Paid

Share this post

Drug Development Executive
Drug Development Executive
Interferon-𝝰 in the causal pathway of Sjögren Disease
Share

Sjögren's Disease (SjD) is a chronic, systemic immunological disorder with poorly defined initiating and driving immune pathways. While there is evidence linking the potent antiviral cytokine Interferon-alpha (IFN-α) to SjD, it has been unclear whether IFN-α directly drives the disease. A recent study presented at the European League Against Rheumatism …

Keep reading with a 7-day free trial

Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Eswar Krishnan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share